I Mab Adr (IMAB)

Nov 30, 2025

Mitchells & Butlers (LON:MAB) Shares Up 7.2% – Should You Buy? - Defense World

Nov 30, 2025

Nov 18, 2025

Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer - Sahm

Nov 18, 2025

Nov 07, 2025

I-Mab Sponsored ADR (IMAB)'s Technical Outlook is Bright After Key Golden Cross - MSN

Nov 07, 2025

Nov 06, 2025

I-Mab (IMAB) Expected to Announce Earnings on Thursday - Defense World

Nov 06, 2025

Nov 04, 2025

Short Interest in I-Mab Sponsored ADR (NASDAQ:IMAB) Increases By 38.8% - MarketBeat

Nov 04, 2025

Nov 01, 2025

What date does NOVABRIDGE BIOS's (NBP) report EarningsEarnings Calendar & Announcement - Zacks Investment Research

Nov 01, 2025

Nov 01, 2025

NovaBridge Biosciences (NAS:NBP) Stock News, Headlines & Updates - GuruFocus

Nov 01, 2025

Nov 01, 2025

NovaBridge Biosciences (NBP) Stock Price, Trades & News - GuruFocus

Nov 01, 2025

Oct 31, 2025

NOVABRIDGE BIOS (NBP) - Zacks Investment Research

Oct 31, 2025

Oct 31, 2025

Total assets of I-Mab Sponsored ADR – NASDAQ:NBP - TradingView

Oct 31, 2025

Oct 31, 2025

I-Mab Sponsored ADR Statistics – NASDAQ:NBP - TradingView

Oct 31, 2025

Oct 31, 2025

NBP Stock Price and Chart — NASDAQ:NBP - TradingView

Oct 31, 2025

Oct 30, 2025

NBPNovaBridge Biosciences. ADR Stock Price and Quote - Finviz

Oct 30, 2025

Oct 29, 2025

I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform - Barchart.com

Oct 29, 2025

Oct 28, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of I-MabIMAB - WV News

Oct 28, 2025

Oct 28, 2025

I-Mab’s (IMAB) Buy Rating Reiterated at BTIG Research - Defense World

Oct 28, 2025

Oct 28, 2025

I-Mab Sponsored ADR (NASDAQ:IMAB) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 28, 2025

Oct 27, 2025

I-Mab stock reaffirmed as Buy at H.C. Wainwright on positive cancer drug data - Investing.com India

Oct 27, 2025

Oct 27, 2025

I-Mab stock reaffirmed as Buy at H.C. Wainwright on positive cancer drug data By Investing.com - Investing.com South Africa

Oct 27, 2025

Oct 24, 2025

I-Mab Rebrands to NovaBridge Biosciences Following Shareholder Approval - TipRanks

Oct 24, 2025

Oct 22, 2025

I-Mab reports 18% response rate for givastomig in gastric cancer trial - Investing.com India

Oct 22, 2025

Oct 22, 2025

I-Mab reports 18% response rate for givastomig in gastric cancer trial By Investing.com - Investing.com South Africa

Oct 22, 2025

Oct 20, 2025

Is Wolfspeed Inc (WOLF) positioned for future growth? - setenews.com

Oct 20, 2025

Oct 18, 2025

Using data filters to optimize entry into I Mab Depositary Receipt2025 Market Overview & Growth Focused Investment Plans - newser.com

Oct 18, 2025

Oct 17, 2025

I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift - Investing.com India

Oct 17, 2025

Oct 17, 2025

I-Mab stock price target raised to $10 by Jefferies on rebranding, new asset - Investing.com India

Oct 17, 2025

Oct 16, 2025

I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO - Investing.com Philippines

Oct 16, 2025

Oct 16, 2025

I-Mab (IMAB) Unveils Strategic Shift with New Business Model and Dual Listing Plan - GuruFocus

Oct 16, 2025

Oct 16, 2025

I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO By Investing.com - Investing.com South Africa

Oct 16, 2025

Oct 15, 2025

I-Mab (NASDAQ:IMAB) Hits New 1-Year HighTime to Buy? - MarketBeat

Oct 15, 2025

Oct 14, 2025

I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference - GlobeNewswire Inc.

Oct 14, 2025

Oct 13, 2025

I-Mab Sponsored ADR (IMAB) Is Up 24.14% in One Week: What You Should Know - MSN

Oct 13, 2025

Oct 13, 2025

Its Stock Has Paid Off Big Time For Liveperson Inc - setenews.com

Oct 13, 2025

Oct 08, 2025

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday - Benzinga

Oct 08, 2025

Oct 06, 2025

What Makes IMab (IMAB) a New Buy Stock - sharewise.com

Oct 06, 2025

Oct 03, 2025

I-Mab Sponsored ADR (NASDAQ:IMAB) Given Average Rating of "Buy" by Analysts - MarketBeat

Oct 03, 2025

Oct 03, 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Oct 03, 2025

Oct 02, 2025

Adversity is less terrifying than hope: Navitas Semiconductor Corp (NVTS) - setenews.com

Oct 02, 2025

Sep 30, 2025

Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 30, 2025

Sep 10, 2025

I-Mab at H.C. Wainwright Conference: Strategic U.S. Shift and Jeva Stomach Focus - Investing.com

Sep 10, 2025

Sep 10, 2025

I-Mab (NASDAQ:IMAB) Now Covered by BTIG Research - Defense World

Sep 10, 2025

Sep 09, 2025

I-Mab stock initiated with Buy rating at BTIG on gastric cancer drug potential - Investing.com

Sep 09, 2025

Sep 09, 2025

I-Mab (NASDAQ:IMAB) Receives Buy Rating from Needham & Company LLC - Defense World

Sep 09, 2025

Sep 08, 2025

I-Mab to initiate phase 2 study for gastric cancer drug in Q1 2026 - Investing.com

Sep 08, 2025

Sep 06, 2025

Adverse Reactions to Tremelimumab, Durvalumab in Liver Cancer - Bioengineer.org

Sep 06, 2025

Sep 04, 2025

C3.ai Posts Downbeat Results, Joins GitLab, Salesforce… - inkl

Sep 04, 2025

Sep 04, 2025

C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAcadian Asset Management (NYSE:AAMI), C3.ai (NYSE:AI) - Benzinga

Sep 04, 2025

Aug 29, 2025

Equities Analysts Offer Predictions for I-Mab Q3 Earnings - MarketBeat

Aug 29, 2025

Aug 28, 2025

I-Mab stock price target raised to $8 from $6 at Brookline Capital - Investing.com

Aug 28, 2025

Aug 28, 2025

Are You Looking for a Top Momentum Pick? Why I-Mab Sponsored ADR (IMAB) is a Great Choice - Yahoo Finance

Aug 28, 2025